New Drug Compound Could Prevent HCV Replication

Here's some interesting news from one of the drug companies. On June 3, Immtech announced they were getting good results from a compound that actually inhibits some infection and replication of the hepatitis C virus.

Of course, the drug is early in development, but it is an important result because it could develop into a drug with a new and different way of fighting HCV.

Immtech is a pharmaceutical company that develops drugs for many infectious diseases, including hepatitis C. Check out their press release for more information.